President Donald Trump’s approach to lowering drug prices has leaned heavily on executive orders and voluntary deals with drugmakers, rather than legislation. (Andrew Harnik / Getty Images) As ...

A drug selected for the latest round of Medicare drug price negotiations stands to get dropped because a lower-cost ...

This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund and the Robert Wood Johnson Foundation.

President Donald Trump attends an event to promote investment in rural health care in the East Room of the White House, Friday, Jan. 16, 2026, in Washington. Standing with the President are Secretary ...

As President Donald Trump touts new deals to cut the cost of blockbuster drugs like Wegovy and Zepbound, he’s barely mentioned Medicare’s drug price negotiation program — even though the government is ...